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WYETH V. LEVINE AND AGENCY PREEMPTION:
MORE MUDDLE, OR CREEPING TO CLARITY?
Ashutosh Bhagwat*
In Wyeth v. Levine,l the Supreme Court held that a decision by the federal Food
and Drug Administration (FDA) (made pursuant to the Federal Food, Drug, and
Cosmetic Act (FDCA)) to approve the marketing of the drug Phenergan and its specific
labeling, did not preempt a tort suit brought pursuant to Vermont state law in which the
plaintiff, Diana Levine, claimed that the manufacturer of Phenergan, Wyeth, had not
provided adequate warnings regarding the risks posed by a particular method of
administration of the drug. The Court's decision has a great deal of practical significance
because it permits a potentially vast number of failure-to-warn products liability suits
against pharmaceutical manufacturers with respect to drugs and labels approved by the
FDA. The case also represents the Court's latest pronouncement in a broader area of
intense public and academic dispute which concerns the power of federal regulatory
agencies to preempt state law.2 The law of preemption generally, and the law of agency
preemption in particular, is infamous for its vagueness and unpredictability. Does Wyeth
v. Levine provide any clarity to this important but frustrating area of law? Or is it just
more muddle? And what insight does Wyeth provide regarding the larger questions
lurking behind this area of law, such as what the relative roles should be of Congress and
administrative agencies in determining the appropriate balance of state and federal
power, and what the role of the courts should be in policing those roles and boundaries?
The short answer is that Wyeth provides some clarity, and a few answers, but it also
continues to a substantial extent along the ambiguous, under-theorized, and frankly
muddled path that the Court has followed in this area. The long answer is, well, long, and
is the subject of the rest of this article. Part I provides background regarding the law of
preemption, the significance of administrative agencies in this area, the Wyeth decision,
and its aftermath. Part II discusses the institutional roles of agencies and Congress in this
area. Finally, Part III discusses the role of the courts vis-A-vis both agencies and
Congress.
* Professor of Law, University of California, Hastings College of the Law (bhagwata@uchastings.edu).
Thanks to Marsha Cohen for extremely helpful comments.
1. 129 S. Ct. 1187 (2009).
2. Some evidence of the significance of this dispute is that just weeks after Wyeth was decided, President
Obama issued an Executive Memorandum on the subject. Memo. from Pres. Barak Obama, to the Heads of
Executive Departments and Agencies, Preemption, (May 20, 2009) (available at http://www.whitehouse.gov/
the press office/Presidential-Memorandum-Regarding-Preemption/) [hereinafter Preemption]. This
memorandum and its significance will be discussed in Part (D).
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I. PREEMPTION, AGENCIES, AND WYETH
A. The "Law" ofPreemption
The Supremacy Clause of Article VI of the Constitution states that
[t]his Constitution, and the Laws of the United States which shall be made in Pursuance
thereof; and all Treaties made, or which shall be made, under the Authority of the United
States, shall be the supreme Law of the Land; and the Judges in every State shall be bound
thereby, any Thing in the Constitution or Laws of any State to the Contrary
notwithstanding. 3
This language is understood to provide that, in the event of any sort of conflict between
federal laws adopted by Congress and the law of any State, federal law shall triumph. It
is also understood to empower Congress to enact legislation which explicitly nullifies
state law in a particular area which Congress believes should be subject to exclusively
federal regulatory control. In either case, the term used to describe the supremacy of
federal law is "preemption."
That, at least, is the conventional story. As Caleb Nelson has pointed out, however,
the truth is rather more complex.4 By its terms, the Supremacy Clause says very little
about state law and certainly does not explicitly authorize Congress to displace state
law.5 Instead, Nelson points out, the primary work done by the Clause is to establish that
federal law is in fact the law of the land, fully enforceable in both state and federal
courts, 6 and that in case of repugnance-what Nelson calls a "logical contradiction"
between state and federal law-judges are directed to follow federal law.7 Stephen
Gardbaum has further argued that while the Supremacy Clause does provide for the
"supremacy" of federal law in case of conflict, it does not authorize Congress to literally
preempt state law, displacing it by express statutory language, because the Supremacy
Clause does not by its terms convey any power to Congress. The power of preemption,
which is to say, the power to completely displace state law from a field, Gardbaum
argues, must derive from the Necessary and Proper Clause of Article I, § 8 (though it
remains true that once Congress has exercised its power, it is the Supremacy Clause
which acts to invalidate all conflicting state law-meaning all state law in the area that
Congress has preempted).9 Indeed, Gardbaum provides evidence that the power of
Congress to preempt state law which does not actually conflict with federal law was
highly controversial for the first century of the Republic, and did not become clearly
established until the twentieth century.' 0 On this view, much of modem preemption law
is confused because it fails to distinguish between two very distinct inquiries, one
3. U.S. Const. art. VI, § 2.
4. Caleb Nelson, Preemption, 86 Va. L. Rev. 225 (2000).
5. Id. at 251-252.
6. Id. at 247-249.
7. Id. at 260.
8. Stephen A. Gardbaum, The Nature ofPreemption, 79 Cornell L. Rev. 767, 770-773 (1994). It should be
noted that Thomas Merrill has expressed his disagreement with this conclusion. Thomas W. Merrill,
Preemption and Institutional Choice, 102 Nw. U. L. Rev. 727, 733-736 (2008).
9. Gardbaum, supra n. 8, at 773-783.
10. Id. at 785-807.
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directed at congressional power and intent, the other directed at whether a conflict exists
between state and federal law, a question having little to do with congressional intent.
Nelson's and Gardbaum's critiques are both quite persuasive and have, as we shall see,
important implications for preemption doctrine.
Whatever the merit of the above arguments, the modem law of preemption, as
articulated by the Supreme Court, is not based on them. Instead, current preemption
doctrine starts off from very different premises. It presumes that the Supremacy Clause is
the source of all preemption. It is also (at least purportedly) based on the fundamental
premise that "the purpose of Congress is the ultimate touchstone in every pre-emption
case[,]" 1 1 a statement that has guided the Court's preemption analysis at least since
1963.12 Finally, and perhaps most significantly, since 1947 the Court has insisted that
[i]n all pre-emption cases, and particularly in those in which Congress has "legislated . . .
in a field which the States have traditionally occupied," . . . we "start with the assumption
that the historic police powers of the States were not to be superseded by the Federal Act
unless that was the clear and manifest purpose of Congress." 13
In other words, there should be a "presumption against preemption." As we will discuss
in more detail later, there is some dispute regarding the exact scope of this presumption,
and there are serious doubts about whether the Court in fact follows such a presumption
with any consistency. But at least in principle, this presumption underlies modem
preemption law.
From these first principles, the Court has constructed an elaborate doctrinal
structure within which preemption claims are to be analyzed. The Court has identified
three, or really four, distinct forms of preemption. 14 The first, "express preemption,"
occurs when Congress enacts explicit language preempting state law. The scope of
express preemption is, of course, defined by the language adopted. The second form of
preemption is called "field" preemption. It occurs when Congress has enacted a
regulatory scheme that is so pervasive in scope that it is reasonable to infer that Congress
left no room for supplemental state regulation. Finally, preemption occurs when there is
an "actual conflict" between state and federal law. As it happens, however, the Court has
identified two quite distinct forms of conflict preemption, thereby increasing the forms of
preemption to four. The first form of conflict preemption occurs when it is physically
impossible to comply with both federal and state law-we might call this "impossibility"
preemption. The second occurs where state law "stands as an obstacle to the
accomplishment and execution of the full purposes and objectives of Congress'15_we
might call this "purpose" or "obstacle" preemption (both terms appear to be in use).
From just this brief summary of the current doctrinal rules in this area, some of the
inconsistencies and ambiguities in preemption doctrine should already be apparent. First
11. Wyeth, 129 S. Ct. at 1194 (quoting Medtronic, Inc. v. Lohr, 518 U.S. 470, 485 (1996).
12. See Lohr, 518 U.S. at 485 (citing Retail Clerks v. Schermerhorn, 375 U.S. 96, 103 (1963)). Similar
language appears even earlier, in Rice v. Santa Fe Elevator Corp., 331 U.S. 218, 230 (1947).
13. Wyeth, 129 S. Ct. at 1194-1195 (quoting Lohr, 518 U.S. at 485 (quoting Rice, 331 U.S. at 230)).
14. See Nelson, supra n. 4, at 226-229, and cases cited therein, for a more detailed summary of the
preemption doctrine.




of all, despite the Court's insistence that Congress's intent be the "touchstone in every
pre-emption case," in fact, at least some preemption analysis, notably "impossibility"
analysis, has absolutely nothing to do with discerning Congress's intent (except for the
unexpressed, though logical, assumption that Congress intends to preempt state laws that
make compliance with federal laws impossible). Second, the clean dividing lines of the
categories of preemption are somewhat deceptive.16 In at least one modem decision, the
Justices divided over whether a statute created express or implied preemption. In that
same decision, the Court acknowledged a great deal of overlap between field and
purpose/obstacle preemption since a finding that a state law is an obstacle to federal
purposes, which most typically occurs when the Court discerns a congressional purpose
of exclusive federal regulation, is really no different from a finding of field preemption
with respect to the specific subject matter as to which Congress intended to prohibit
duplicative regulation.18 Finally, and most broadly, it should be noted that of the four
forms of preemption, only one-express preemption-flows directly from statutory
language. The others are all forms of "implied preemption," which means that the Court
is discerning congressional intent from the broader structure of statutes. Moreover,
realistically in many implied preemption cases, the "congressional intent" that the Court
discerns is much more a product of judicial construction than any actual congressional
intent-indeed, since by definition all implied preemption cases involve situations where
Congress did not include statutory language addressing preemption, it is reasonable to
believe that Congress had absolutely no formed intent on the preemption question.
Among the three forms of implied preemption, impossibility preemption is
uncontroversial and unproblematic because, while it derives from congressional "intent"
in an essentially fictional sense, it does flow quite naturally from the language of the
Supremacy Clause. Field and purpose/obstacle preemption, however, flow from the
language of neither a statute nor the Constitution, raising serious questions about their
provenance. Indeed, the combination of the Court's two founding principles, that
preemption flows from Congress and that there is a presumption against preemption,
arguably suggests that neither form of preemption should exist. If Congress has not
spoken to the subject, and if compliance with both state and federal law is possible, on
what authority do courts find preemption?
In short, preemption doctrine is, on its face, a complex, well-established body of
doctrine. Look under the surface, however, and both logic and clarity vanish. Even the
surface logic that characterizes preemption doctrine disappears, however, when one
examines our next topic, which is the role of administrative agencies in preempting state
law.
B. Preemption andAgencies-The Issues
The description of preemption law and doctrine set forth above is based on a vision
16. See generally Karen A. Jordan, Agency Preemption and the Shimer Analysis: Unmasking Strategic
Characterization by Agencies and Giving Effect to the Presumption Against Preemption, 2008 Wis. L. Rev. 69,
78-79.
17. Gade v. Natl. Solid Wastes Mgt. Assn., 505 U.S. 88 (1992).
18. Id. at 104 n. 2.
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of federal law as constituting statutes passed by Congress. That premise, however, is
thoroughly out of date. Since the New Deal revolution of the 1930s, most federal law is,
in fact, made by administrative agencies. The typical model for modern federal
lawmaking is for Congress to pass a statute of greater or less specificity depending on the
circumstances, and then empowering an administrative agency such as the Federal
Communications Commission (FCC) or the Environmental Protection Agency (EPA) to
implement the statute through regulations. In practice, it is those agency's regulations
which constitute the binding "law" that citizens must follow.
Where do those agency regulations fall within the law of preemption? The
conventional wisdom, as stated by the Supreme Court, is that "[f]ederal regulations have
no less pre-emptive effect than federal statutes." 19 Behind this bland statement, however,
lurk many questions and uncertainties. To better understand these issues, it is useful to
set forth a typology of the different ways in which agencies can become involved in
preemption issues.
First, it is possible for Congress to explicitly delegate to an agency power to
preempt state law (as it sometimes does, though not with great frequency), and an agency
can exercise that power to adopt a regulation expressly preempting state law.20
Currently, it seems almost universally accepted that, given the demise of the
Nondelegation Doctrine, this is permissible (though Bradford Clark raises some
questions 21).
Second, Congress can grant to an agency general rulemaking power-i.e., the power
to adopt regulations with the force of law-without any mention of preemption, and the
agency can exercise that power to adopt a regulation expressly preempting state law. 22
There is an ongoing academic debate, discussed in the next section, regarding the
permissibility of such regulations. The Supreme Court has never explicitly resolved this
question, though Justice Stevens's dissent (joined by Chief Justice Roberts and Justice
Scalia) in the recent Watters v. Wachovia Bank, N.A. strongly suggests that he would not
permit agencies to preempt state law using general rulemaking authority.23
Third, Congress can enact a statute which itself contains an express preemption
clause and the administrative agency charged with administering the statutory scheme
can interpret the scope of that clause. Again, there is an ongoing academic debate over
the level of deference (if any) that courts should accord to such interpretations. In
particular, there is disagreement about whether such interpretations should be accorded
the very high level of deference, called Chevron deference, 24 the lower level of
deference, termed Skidmore deference,25 or no deference at all. The Supreme Court has
19. Fidelity Fed. Say. & Loan Assn. v. de la Cuesta, 458 U.S. 141, 153 (1982); see also La. Pub. Serv.
Commn. v. FCC, 476 U.S. 355, 369 (1986) ("Pre-emption may result not only from action taken by Congress
itself; a federal agency acting within the scope of its congressionally delegated authority may pre-empt state
regulation"); N.Y.C. v. FCC, 486 U.S. 57, 63-64 (1988).
20. See e.g. 47 U.S.C. § 253(d) (2009).
21. Bradford R. Clark, Separation of Powers as a Safeguard of Federalism, 79 Tex. L. Rev. 1321, 1433-
1435 (2001).
22. See e.g. N Y. v. FCC, 486 U.S. 57 (1988).
23. 550 U.S. 1, 40 (2007) (Stevens, J., dissenting).
24. See Chevron U.S.A v. NRDC, 467 U.S. 837 (1984).
25. See Skidmore v. Swift, 323 U.S. 134 (1944).
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not yet clearly resolved this issue. 26
Fourth, it might be that neither a statute nor agency regulations expressly mention
preemption, but an agency expresses its views regarding the scope of implied
preemption, typically purpose/obstacle implied preemption (though, in principle, also
field preemption), created by the governing statute that it administers. Such agency
pronouncements are typically expressed through relatively informal modes, such as
preambles to regulations, policy statements, memorandums, amicus briefs, or
interpretative rules, all of which lack the force of law. The question of whether courts
should defer to such agency views is a highly contentious one, on which commentators
sharply disagree, and on which the Court has given extremely mixed signals.27 This
issue was raised again in the Wyeth case and again the Court failed to clearly resolve it.
Fifth, an agency might adopt a substantive regulation, and a state law might
conflict with that regulation. 28 In this situation, it is well established that preemption
does follow. Note that in many cases involving conflicts with agency regulations, state
laws can also be said to conflict with the congressional statute authorizing the regulation.
In that situation, preemption is, of course, completely unproblematic. But the Court has
made clear (in the quotes beginning this section) that even when a state law conflicts
only with a regulation and not a statute, preemption still follows. Again, there is some
academic debate over the propriety of such preemption, 29 but it is well accepted by the
Court and seemingly by most commentators.
That, then, is a brief summary of the difficult, unresolved, and highly contested
issues that arise when administrative agencies become involved in preemption. Let us
turn now to a brief summary of the current academic debates in this area.
C Preemption and Agencies-The Academic Debate
In recent years, preemption generally, and the role of agencies in preemption in
particular, have become the subject of intense academic interest. Caleb Nelson's path
breaking article on the textual and historical roots of preemption doctrine, published in
2000,30 probably represents the beginning of this trend, but it was several years later that
the scholarship on agencies and preemption began to burgeon.3 1 In 2008 alone, both the
Duke Law Journal and the Northwestern Law Review published symposium issues
26. See Watters, 550 U.S. at 20-21 n.13 (refusing to resolve the question); but see id. at 41-42 (Stevens, J.,
dissenting) (arguing against Chevron deference); Smiley v. Citibank (SD.), N.A., 517 U.S. 735, 744 (1996)
("We may assume (without deciding) that the latter question [of whether a statute is pre-emptive] must always
be decided de novo by the courts").
27. Compare Geier v. Am. Honda Motor Co., 529 U.S. 861, 883 (2000) ("We place some weight upon
DOT's interpretation of FMVSS 208's objectives and its conclusion, as set forth in the Government's brief,
that a tort suit such as this one would 'stand as an obstacle to the accomplishment and execution' of those
objectives") and Lohr, 518 U.S. at 495-496 with Bates v. Dow Agrosciences, L.L. C., 544 U.S. 431, 449-452
(2005) (finding no preemption despite the contrary position of the agency) and Wyeth, 129 S. Ct. at 1201
(declining to defer to the agency's position).
28. See e.g. U.S. v. Shimer, 367 U.S. 374 (1961).
29. See generally Gillian E. Metzger, Administrative Law as the New Federalism, 57 Duke L.J. 2023, 2069
n. 175 (2008).
30. Nelson, supra n. 4.
3 1. See generally Stuart Minor Benjamin & Ernest A. Young, Tennis with the Net Down: Administrative
Federalism Without Congress, 57 Duke L.J. 2111, 2131 n. 79 (2008) (citing scholarship).
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dedicated to the topic of preemption;32 several other major articles on the topic were
published that year as well. 3 3 Clearly, something is in the air (not least the Supreme
Court's decision to decide the Wyeth v. Levine case, one suspects).
The academic debate on agencies and preemption touches upon, and demonstrates
disagreement over, many of the specific issues regarding the role of agencies in
preempting state law noted above. Underlying these specific points, however, is an
overarching debate about institutional strengths and weaknesses. At its core, this debate
concerns whether Congress or administrative agencies (or, for that matter, federal courts)
are best placed to determine the proper balance between federal and state regulatory
authority, which is of course the core concern triggered by preemption. A number of
scholars, including Nina Mendelson, 34 Thomas Merrill, 35 Stuart Benjamin, 36 Ernest
Young,37 and Scott Keller,3 8 favor Congress (though there is some disagreement within
this group about whether agencies have any institutional strengths in this area at all). The
essential argument made by these scholars harkens back to Herbert Wechsler's famous
article on the political safeguards of federalism. 39 Wechsler's argument, in essence, was
that judicial enforcement of federalism-based limits on Congress's power was
unnecessary because state representation in Congress ensured that Congress itself would
adequately take account of and protect the interests of the sovereign states. The group of
scholars noted above turn this argument on its head by pointing out that the safeguards
that Wechsler attributes to Congress do not exist within administrative agencies. Ernest
Young in particular (drawing on previous work by Bradford Clark) identifies two
different kinds of safeguards for state interests and autonomy in Congress: political
safeguards, arising from the fact that states are represented in Congress, and procedural
safeguards, arising from the sheer difficulty of enacting federal legislation. 40 As Young
points out, neither of these safeguards exist at the agency level. States are obviously not
represented within agencies, which are purely national, unelected institutions, and
agency action faces far fewer barriers than legislative action (that is, of course, the whole
point of having agencies in the first place).41 Young also rejects the argument, made by
Larry Kramer, 42 that the involvement of state officials in implementing cooperative
federalism programs provides some assurance against federal administrative
overreaching, pointing out that such cooperative programs may actually have the reverse
32. Thirty-Eighth Annual Administrative Law Issue, 57 Duke L.J. 1933 et seq. (2008); Symposium on
Ordering State-Federal Relations Through Federal Preemption Doctrine, 102 Nw. U. L. Rev. 503 (2008).
33. See Scott A. Keller, How Courts Can Protect State Autonomy from Federal Administrative
Encroachment, 82 S. Cal. L. Rev. 45 (2008); Catherine M. Sharkey, Products Liability Preemption: An
Institutional Approach, 76 Geo. Wash. L. Rev. 449 (2008); Jordan, supra n. 16.
34. Nina A. Mendelson, Chevron and Preemption, 102 Mich. L. Rev. 737, 779-791 (2004) [hereinafter
Mendelson, Chevron and Preemption]; Nina A. Mendelson, A Presumption Against Agency Preemption, 102
Nw. U. L. Rev. 695, 717-722 (2008) [hereinafter Mendelson, A Presumption].
35. Merrill, supra n. 8 at 755-756.
36. Benjamin & Young, supra n. 31, at 2146-2147.
37. Id.; Ernest A. Young, Executive Preemption, 102 Nw. U. L. Rev. 869, 876-878 (2008).
38. Keller, supra n. 33, at 62.
39. Herbert Wechsler, The Political Safeguards of Federalism: The Role of the States in the Composition
and Selection of the National Government, 54 Colum. L. Rev. 543 (1954).
40. Young, supra n. 37, at 876 n. 44 (citing Clark, supra n. 21).
41. Id. at 878.
42. Larry Kramer, Understanding Federalism, 47 Vand. L. Rev. 1485, 1544 (1994).
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effect, that of eroding state officials' loyalty to localism. 43 Nina Mendelson and Thomas
Merrill build on this argument by pointing out that the institutional structure of agencies
might in fact make them particularly ill-suited to consider the benefits of preserving state
autonomy because of agencies' narrow focus on achieving particular regulatory goals
rather than preserving the broader structure of our system of government. 44 All of these
are powerful arguments and make intuitive sense. Congress, after all, is made up of
locally elected politicians who continue to have political roots and alliances in local
jurisdictions throughout this nation. Agencies, on the other hand, are centralized,
national, and unelected entities whose senior officials inevitably live and work in and
around Washington, D.C. Such organizations have no particular links to the states and
have an obvious bias in favor of expanding federal and, hence, their authority. In short,
this argument goes, if agencies are authorized to preempt state law, they will do so far
more often and more broadly than would be optimum from an overall perspective
because agencies have no incentives to value continuing local control and state
autonomy, despite the fact that these are important values in our constitutional system.
Despite the intuitive power of the arguments set forth above, there is an admittedly
smaller, but significant group of scholars who argue to the contrary, that under modem
circumstances it is agencies, and not Congress, who are best situated to determine the
appropriate balance between national and state power. This argument has been advanced
most clearly and strongly by Brian Galle and Mark Seidenfeld. 45 Galle and Seidenfeld
argue that, on the criteria of transparency, deliberation, and accountability, agencies
outperform Congress and, indeed, the courts (though I will focus on Congress) in their
capacity to evaluate issues regarding the proper delineation of state and federal
authority.46 Regarding transparency, they argue that the notice-and-comment process for
rulemaking which agencies must follow under the Administrative Procedure Act (APA)
(as interpreted by the courts) ensures that agencies are highly transparent in the sense
that agencies are obliged to disclose their thinking, and the reasons and data behind their
thinking, to the public, and it is relatively easy for members of the public to
communicate with agency staff.47 With respect to Congress, on the other hand, though
Congress operates in the public light, its actual decision-making process is often
shrouded in secrecy and members of the public, other than well-organized interest
groups, have effectively no access to members of Congress. With respect to deliberation,
Galle and Seidenfeld emphasize the impact of modem "hard look" judicial review on
agency decision-making.48 Under hard look review, as articulated in Supreme Court
cases such as Citizens to Preserve Overton Park v. Volpe49 and Motor Vehicle
Manufacturers Association of the United States v. State Farm Mutual Automobile
43. Young, supra n. 37, at 879-880.
44. Mendelson, A Presumption, supra n. 34, at 717-718; Mendelson, Chevron and Preemption, supra n.
34, at 779-791; Merrill, supra n. 8, at 755-756.
45. Brian Galle & Mark Seidenfeld, Administrative Law's Federalism: Preemption, Delegation, and
Agencies at the Edge ofFederal Power, 57 Duke L.J. 1933 (2008).
46. Id at 1948-1984.
47. Id. at 1955.
48. See id
49. 401 U.S. 402 (1971).
204 Vol. 45:197
WYETH V. LEVINE AND AGENCYPREEMPTION
Insurance Company,50 courts reviewing a final agency decision under the APA's
"arbitrary and capricious" standard of review 5 1 must carefully evaluate the agency's
decision and reasoning to ensure that the agency considered the relevant factors and
acted rationally. The threat of such review, in turn, requires agencies to act carefully and
deliberatively in their decision-making process. Congress, on the other hand, is
notoriously undeliberative and also lacks the expertise that agency staff enjoy which
imbues agency decision-making with a sophistication that Congress necessarily lacks.52
Finally, Galle and Seidenfeld conclude, rather counter-intuitively, that even on the
question of political accountability, agencies outperform Congress. Congress is of course
directly elected, suggesting a high level of accountability, but in fact Galle and
Seidenfeld argue, the enormous benefits of incumbency and voters' lack of knowledge
makes that accountability somewhat illusory, especially in the regulatory arena where
voter knowledge is often extremely limited. Agencies, on the other hand, though not
elected, are subject to substantial oversight by Congress and the President, creating
substantial political accountability, especially because of presidential oversight. In
addition, agencies' ability to act quickly means that their decisions are more likely to
reflect current political preferences, while congressional statutes because of inertia may
well reflect preferences that have since changed.53 In short, Galle and Seidenfeld argue
that in the world of the modem, administrative state, administrative agencies are not only
capable of properly taking into account state interests, they are better placed to do so
than Congress.
Galle and Seidenfeld are not the only modern scholars touting the strengths of
agencies. Gillian Metzger has likewise defended agencies' incentives and ability to
properly consider state interests. She emphasizes the deep relationships between agencies
and state officials through lobbying, cooperative federalism programs, and contacts in
local offices, as an important avenue for the assertion of state interests. She also argues
that agency expertise makes them especially well qualified to assess how state and
federal authority interact in particular areas, a critical factor in determining the need for
preemption. 54 Catherine Sharkey similarly emphasizes the significance of agency
expertise in permitting administrative agencies to provide guidance regarding the need
for uniform federal regulation of a particular subject (which would necessitate
preemption of state regulation).55 Indeed, even Nina Mendelson, who is generally hostile
to agency preemption, has conceded that agencies do have some incentives to consider
state interests in their decision-making process and that agencies have valuable insights
to provide regarding the need for preemption. 56
In short, we find in the recent scholarship two starkly different visions of the
institutional competency and incentives of administrative agencies to consider the
50. 463 U.S. 29 (1983).
51. See 5 U.S.C. § 706(2)(A) (2009).
52. Galle & Seidenfeld, supra n. 45, at 1962-1979.
53. Id. at 1979-1984.
54. Metzger, supra n. 29, at 2074-2083.
55. Sharkey, supra n. 33, at 485-490.




interests of the states and to preserve state autonomy. Unsurprisingly, these differences
in institutional outlooks result in very different prescriptions regarding agency authority
to preempt. A number of scholarly proponents of congressional authority (and opponents
of agency authority), for example, have argued in favor of "clear statement" rules, under
which agencies would be able to preempt state law only if Congress has enacted
legislation which clearly and unambiguously authorizes such preemption. Thomas
Merrill, for example, would require a "super-strong clear statement" before agencies
could preempt state law. 57 Nina Mendelson similarly advocates "a showing that
Congress clearly wishes to preempt state law" before an agency can preempt state law, 58
and Ernest Young suggests that a high level of clarity be required before agencies
preempt state law. 59 I read these arguments as limited to express preemptions of state
law by agency regulation, not to implied preemption, especially actual conflict
preemption, since presumably there is widespread agreement that, when it is impossible
for a regulated entity to comply with both a substantive federal regulation and a state
law, the state law must yield (any other rule would permit the states to hamstring federal
regulatory efforts). Nonetheless, the impact of these scholars' proposals would be to
eliminate the second category of agency preemption discussed above 60 and to narrow the
first category to instances where Congress has spoken with exceptional clarity. Scott
Keller would go one step further and create a "clear statement canon" which would
require Congress to clearly state its intent to authorize such agency action before an
agency could even substantively regulate-much less preempt-in an area of traditional
state authority.61 The impact of his proposal on preemption would be to substantially
narrow even the fifth category of agency preemption, which is actual conflict preemption
between regulations and state law, because it would eliminate many substantive agency
regulations.62
In addition to clear statement requirements, scholars hostile to administrative
preemption also tend to favor reduced, or no, deference to agency interpretations
regarding the preemptive scope of congressional statutes or of substantive agency
regulations. Nina Mendelson, for example, has argued that agency preemption
interpretations should receive the lower, Skidmore level of deference from courts, not
Chevron deference.63 Stuart Benjamin and Ernest Young, writing together, similarly
conclude that agency statements regarding the preemptive effect of federal law "would
add relatively little to a preemption inquiry; the preemptive effect of federal law would
have to be grounded in actions by Congress, not the agency's judgment." 64 Finally,
Thomas Merrill and Ernest Young (writing alone) both advocate an approach to
57. Merrill, supra n. 8, at 767.
58. Mendelson, A Presumption, supra n. 34, at 710.
59. Young, supra n. 37, at 897-898.
60. See supra pt. 1(B).
61. Keller, supra n. 33, at 90-91.
62. In truth, the ambiguity of the phrase "area of traditional state authority" probably makes Keller's
proposal impractical because its impact would be to disempower federal agencies from regulating vast areas of
human activity. A narrower focus on clear statement requirements for preemption, on the other hand, is much
more practical.
63. Mendelson, Chevron and Preemption, supra n. 34 at 797-798.
64. Benjamin & Young, supra n. 31, at 2140-2141.
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deference on preemption issues which is sui generis and which modulates the level of
deference courts give to agencies depending on such factors as the extent to which the
agency permitted state actors to participate in its decision-making and to which it
explicitly considered state interests.65 On its face, thus, there appears to be quite broad-
ranging agreement among this group of scholars on the deference question, and none of
the scholars appear to distinguish, on the question of deference, between agency
interpretations of express preemption provisions and agency interpretations of the
implied preemptive scope of a statute (or for that matter, a regulation). Giving some
support to this approach to deference is the fact that in a dissenting opinion in 2000's
Geier v. American Honda Motor Company case, Justice Stevens (joined by Justices
Souter, Thomas, and Ginsburg) argued that because of institutional differences between
agencies and Congress, agency claims of preemption should not be accorded deference
unless they were adopted through a "formal notice-and-comment rulemaking," which
agency interpretations of preemptive effect almost never are.66 And in his 2007 dissent
in Watters v. Wachovia Bank, N.A. (this time joined by Chief Justice Roberts and Justice
Scalia), Justice Stevens reiterated his view that agency conclusions regarding the
preemptive scope of a federal statute should not receive Chevron deference. 67 Note that
adding up these votes, five of the current Justices have joined opinions disclaiming
deference to agency findings of preemption.
Despite this seeming consensus, however, there are, in fact, some interesting
divisions, even among scholars who are generally suspicious of agency preemption,
regarding the scope of deference, or non-deference, due agencies. With respect to agency
interpretations of express statutory preemption provisions, all these scholars seem to
agree that only reduced deference is due. With respect to implied purpose/obstacle
preemption, this group seems to agree that no deference is due on the ultimate question
of whether preemption exists. For some scholars, such as Scott Keller and Bradford
Clark,68 that seems to be the end of the matter given agencies' institutional weaknesses.
However, several other scholars would accord deference to agencies regarding the
meaning and substantive reach of a statute, even though that interpretation has obvious
implications for the implied preemptive effect of the statute. Ernest Young, for example,
believes that an agency's substantive interpretations must be accorded Chevron
deference even when such interpretations have preemptive implications and (quite
reasonably) he reads the Supreme Court's decision in Smiley v. Citibank (S.D.) as
supporting this distinction.69 Nina Mendelson also concedes that, because of their
expertise, agencies have important contributions to make regarding the meaning of
federal law and the extent to which overlapping state law might interfere with achieving
65. Merrill, supra n. 8, at 775-776; Young, supra n. 37, at 891-894.
66. Geier, 529 U.S. at 912. The reason that agency interpretations are typically announced informally rather
than through notice-and-comment rulemaking is that a regulation/interpretation adopted through notice and
comment itself has the force of law and can directly preempt state law, rather than merely interpret the
preemptive scope of a statute (this assumes, of course, that the agency has been properly delegated preemptive
power by Congress, a topic discussed earlier).
67. Watters, 550 U.S. at 41 (Stevens, J., dissenting).
68. See Keller, supra n. 33; Clark, supra n. 21.
69. Young, supra n. 37, at 885 (citing Smiley, 517 U.S. at 744).
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federal goals. 70 Thomas Merrill, on the other hand, explicitly rejects the Smiley approach
of granting Chevron deference on substantive but not preemptive questions, 7 1 yet even
he concedes that agencies have a great deal of institutional expertise, and some important
comparative advantages, in assessing pragmatic factors such as how federal and state law
actually interact in an area.72 Interestingly, the ultimate position adopted by these
scholars has marked similarities to Catherine Sharkey's ultimate conclusions, reflecting
as they do a distinction between agency views on regulatory issues and agency views on
ultimate preemption questions7 3 despite the fact that Sharkey seems generally less
hostile to agency preemption.
There is thus a range of opinions, even among scholars generally hostile to agency
preemption, regarding the role agencies may play in this area. On the other side, Brian
Galle, Mark Seidenfeld, and Gillian Metzger are much more clear in their position,
which is that there should be no special barriers to agency preemption. Preemption, in
their view, is an exercise of federal power like any other and, in the modem, post-New
Deal world, with the demise of the Nondelegation Doctrine, agencies are freely
permitted to exercise federal power so long as a proper congressional delegation exists.
Moreover, as discussed above, these authors believe that, in light of the state of modem
administrative law and the requirements that it imposes on agencies, agencies are better
placed than other federal institutions to assess the optimum balance between federal and
state power. Given these views, Galle and Seidenfeld not surprisingly completely reject
any "clear statement" requirement for Congress to delegate preemptive power to
agencies. 74 In their view, any such requirement is too limiting on agency authority and
unnecessary. They would require agencies to exercise delegated preemptive power only
through notice-and-comment rulemaking, subject to hard look judicial review,75 but that
is a minor limitation since agency rules with the force of law are typically the product of
such a process. 76 On the question of deference to agency interpretations regarding
preemptive effect, Galle and Seidenfeld's view is more nuanced. They concede that
Chevron deference may be too inflexible, but they also think that Skidmore deference
denies agencies too much power, in particular the power to reconsider judicial
pronouncements regarding the preemptive effect of statutes. Ultimately, they advocate a
multifactor test which has similarities to the tests proposed by scholars such as Thomas
Merrill and Ernest Young, but which does seem, on the whole, to grant agencies
significantly more discretion. 77 Gillian Metzger is less explicit than Galle and Seidenfeld
on the specific issues discussed here, but if anything, she seems to have even fewer
70. Mendelson, A Presumption, supra n. 34, at 718.
71. Merrill, supra n. 8, at 773-774.
72. Id. at 755-756, 775-776.
73. Sharkey, supra n. 33, at 491.
74. Galle & Seidenfeld, supra n. 45, at 2006-2009.
75. Id. at 2011.
76. This leaves open the question of the preemptive force of agency adjudications, whether formal or
informal, since such actions have the force of law but (especially in the case of informal adjudications) are not
the product of a formal process. In truth, however, it is hard to see how an agency adjudication, which is
typically binding only on the parties, can have broad preemptive effect except as effectuated by a statute or
substantive regulations.
77. Id. at 1996-2005.
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qualms about agency preemption. For example, Metzger clearly rejects any clear
statement rules in this area on the grounds that they would interfere excessively with
federal regulatory programs. And her general view that ordinary administrative law is
sufficient to protect state interests in the federal administrative process79 suggests
strongly that, in her view, ordinary deference principles should be applied in this area
with no special rules reducing deference on preemption issues.80
What explains these sharp differences regarding the scope of agency authority to
preempt state law? Part of the explanation, as noted earlier, lies in differing views
regarding the institutional capacity of agencies to properly take into account the interests
of the states. But that is not the full story. A deeper, underlying difference animating the
divisions among these scholars relates to their views of federalism itself, its nature, and
the reasons for preserving it. Defenders of agency authority such as Brian Galle, Mark
Seidenfeld, and Gillian Metzger tend to view federalism in functional and pragmatic
terms, as an institutional mechanism for achieving optimum public policy. Galle and
Seidenfeld are quite explicit on this matter. The following paragraph, which is worth
quoting in its entirety, illustrates their view quite clearly:
At the outset, it deserves mention that this Article views the aims of federalism,
whether in its abstract or economic sense, as improving the regulatory process, not the
,preservation of state regulatory prerogatives per se. Hence, the issue is not which
institution best enables state influence over regulation, but rather which institution fosters
state influence that will enhance public welfare, and not simply state officials'
opportunities for rent seeking. This view, however, does not universally discount the value
of having a sovereign independent of the federal government with the power to regulate.
Rather, it credits the availability of dual sovereignty only as a functional matter-that is,
only when that availability is related to regulatory outcomes and not simply out of some81posited formalistic preference for protection of dual sovereignty.
Metzger similarly insists that the question of whether administrative agencies "can
offer adequate protection to state regulatory interests" should be answered not by
requiring actual "success in derailing proposed administrative actions that adversely
impact the states," but only by ensuring "that state regulatory interests receive careful
consideration by federal officials[.]" 82 The reason, she explains, is that insisting on the
actual preservation of state authority is inconsistent with the modem assumption that
Congress and agencies do possess the power to regulate activities and to preempt state
law in the process. Thus Metzger, like Galle and Seidenfeld, seems to place little value in
the actual preservation of state regulatory authority. Instead, her focus is on the
efficiency of the federal administrative process.
Scholars generally hostile to agency preemption have a very different view of
federalism. Instead of focusing on functional roles and pragmatic policy outcomes, they
tend to see federalism as a formal, structural principle, to be adhered to regardless of its
78. Metzger, supra n. 29, at 2071-2072.
79. Id. at 2083-2086, 2108-2109.
80. Cf id. at 2071 (noting scholarly arguments against deference in this area, and implying, without stating
explicitly, that they are misplaced).
81. Galle & Seidenfeld, supra n. 45, at 1949 (footnote omitted); see also id. at 1971-1972.
82. Metzger, supra n. 29, at 2072-2073.
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efficacy. Stuart Benjamin and Ernest Young, for example, forthrightly acknowledge that
their approach to federalism is "formalist" in the sense that it requires adherence to a
particular set of institutional rules (in this case, congressional primacy on matters of
preemption) regardless of whether those rules best advance particular values. 83 Writing
on his own, Ernest Young is even more explicit that at the core of federalism doctrine "is
a general commitment to balance between national and state authority. That commitment
is grounded not in the capacity of federalism to promote various policy values ... but
rather in constitutional fidelity." 84 And Tom Merrill, describing the basic principles of
federalism, emphasizes not the practical value of a federal system, but rather the
structural principle that "the state governments are the locus of general sovereignty in the
American federal system." 85 In short, the scholarly debate over agency preemptive
authority reveals fissures not only on institutional details, but also on basic principles of
American constitutionalism.
D. The Wyeth v. Levine Decision
Into this maelstrom of doctrinal confusion and scholarly divisions, the Supreme
Court leapt with its decision in Wyeth v. Levine. Wyeth is perhaps the most significant
Supreme Court preemption decision since the groundbreaking 1992 case Cipollone v.
Liggett Group, Inc.86 which inaugurated the modern trend of finding state common law
tort claims preempted by federal law.
1. Facts and Regulatory Background
Diana Levine, the plaintiff in this case, was a professional musician and a resident
of Vermont who suffered from serious migraine headaches. On April 7, 2000, she visited
her local clinic to obtain treatment for a severe migraine. She was originally given
intramuscular injections of Demerol for her headache and Phenergan, a drug
manufactured by defendant Wyeth, for her nausea. Because this treatment did not work,
she returned later in the day and received second doses of both drugs. This time, the
drugs were administered intravenously, using the "IV-push" method under which a drug
is directly injected into a patient's veins. For reasons that are not entirely clear, however,
the Phenergan escaped from Levine's vein and came into contact with arterial blood.
Phenergan is known to cause irreversible gangrene if it enters an artery, and Levine
developed gangrene. Doctors were forced to amputate first her right hand, and then her
entire forearm, to prevent the spread of the gangrene, as a consequence of which Levine
was no longer able to pursue her musical career and, of course, incurred pain and
suffering. Levine sued her clinic, which settled her claim, and also sued Wyeth in state
court on the theory that Phenergan's labeling did not adequately warn of the dangers
associated with IV-push administration of Phenergan and, more broadly, that Phenergan
was not safe for intravenous administration. Wyeth raised the defense that Levine's
83. Benjamin & Young, supra n. 31, at 2130.
84. Young, supra n. 34, at 872 (footnote omitted).
85. Merrill, supra n. 8, at 745.
86. 505 U.S. 504 (1992).
87. Wyeth, 129 S. Ct. at 1190-1191.
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failure-to-warn claims were preempted by federal law, as a matter of both field and
conflict preemption. The trial judge rejected Wyeth's defense and a jury ultimately
awarded Levine $7,400,000 in damages on her failure-to-warn claim. The Vermont
Supreme Court affirmed the jury verdict, as well as the trial judge's rejection of Wyeth's
preemption defense, and the United States Supreme Court granted certiorari on the
preemption issue.88
To understand the nature of Wyeth's preemption claim, some understanding is
necessary of the drug Phenergan and the federal regulatory scheme governing drugs.
Phenergan is a brand name for promethazine hydrochloride, an antihistamine used to
treat allergies and nausea. It has been approved for use in the United States since 1955.
Phenergan may be administered either intramuscularly or intravenously, and if
intravenously, either through the IV-push method or through the IV-drip method
whereby the drug is added to a saline solution which enters the patient's veins through an
already inserted IV catheter. Evidence at Levine's trial indicated that the risk of gangrene
posed by Phenergan can be almost entirely eliminated through the use of IV-drip (or
intramuscular injection) rather than the IV-push method. 8 9 Based on this evidence,
Levine argued that Wyeth should have included stronger warnings on the Phenergan
label (as discussed below, Wyeth did include some warnings) against the use of the IV-
push method, and that the failure to do so made the product defective. The jury accepted
these arguments and also found that Wyeth's failure to warn was the cause of Levine's
injury-findings which were of course binding on the United States Supreme Court in the
course of its review.9 0
Wyeth's preemption defense was based on the nature of the regulatory scheme
governing the sale of drugs in this country. Under the FDCA, before a new drug can be
sold in the United States, it must be approved for sale by the FDA. During this approval
process the FDA reviews both evidence that the drug is safe and effective and the
adequacy of the warning labels accompanying the drug. Injectable Phenergan was first
approved by the FDA for sale in 1955. During the 1970s and 1980s, Wyeth and the FDA
corresponded regarding the need for stricter warnings on the risks of gangrene resulting
from IV-push administration and Wyeth duly added such labels. 91 It should be noted,
though, that the majority and dissenting Justices in Wyeth appear to disagree on the
amount of attention the FDA gave to these issues: the majority cites the trial judge's
finding that the FDA "paid no more than passing attention to the question whether to
warn against TV-push administration of Phenergan[,]"92 while the dissent specifically
rejects this finding.9 3 Regardless, it is undisputed that when Levine's accident occurred
in 2000, Phenergan's labeling did contain extensive language warning of the risk of
gangrene associated with intravenous administration of Phenergan and also contained
language stating that IV-drip administration is "usually preferable" to IV-push
administration. According to the Supreme Court majority, however, Phenergan's
88. Id at 1191-1193.
89. Id. at 1190, 1192.
90. Id. at 1193.
91. Id. at 1192.
92. Wyeth, 129 S. Ct. at 1193, 1199.
93. Id. at 1226 (Alito, J., dissenting).
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"labeling did not contain a specific warning about the risks of IV-push
administration[,]" 94 another finding that the dissent rejects. 9 5
Two final and critical facts regarding the FDA regulatory scheme complete this
regulatory background. The first is that FDA regulations permit drug companies to add
or strengthen warnings on already-approved drugs without prior approval by the FDA so
long as the company files a supplemental application with the FDA. 96 The second is that
while historically (including in 2000 when the accident occurred) the FDA had taken the
position that its regulation of new drugs did not preempt state tort law claims, 9 7 that
changed in 2006. That year, the FDA issued new regulations regarding the content and
form of drug labels and attached to those regulations a Preamble which stated that, in the
view of the agency, FDA approval of a drug label preempted contrary state law tort
claims because the FDCA made an approved label both a "floor" and a "ceiling," thereby
prohibiting states from requiring stricter warnings.9 8 In particular, the FDA Preamble
stated that state law failure-to-warn claims "threaten FDA's statutorily prescribed role as
the expert Federal agency responsible for evaluating and regulating drugs." 99 This
Preamble, it should be noted, was not adopted through notice and comment rulemaking
because it was added to the regulations after the rulemaking process had been
completed-to the contrary, the FDA's original notice of proposed rulemaking in this
proceeding specifically disclaimed any preemptive effect. 100 Nonetheless, when the
Supreme Court considered the Wyeth case during the October, 2008 Term, it was faced
with an official agency interpretation, reiterated in an amicus brief filed by the United
States, that the FDCA preempted Levine's claims.
Based on this regulatory structure and history, Wyeth argued that the FDCA,
combined with the FDA's approval of Wyeth's label for Phenergan, preempted Levine's
claims. In the U.S. Supreme Court, Wyeth pursued two different conflict preemption
claims: 10 1 first, that it was physically impossible to comply with both federal law and the
state law duty implied by the jury verdict; and second, that in any event the state law tort
action was an "obstacle to the accomplishment and execution of the full purposes and
objectives of Congress."102 We now turn to the Court's analysis of these claims.
2. Majority Opinion
In the U.S. Supreme Court, Wyeth v. Levine produced four opinions: a majority
opinion by Justice Stevens, joined by Justices Kennedy, Souter, Ginsburg, and Breyer; a
short concurring opinion by Justice Breyer; a lengthy opinion by Justice Thomas
concurring in the judgment only; and a dissenting opinion by Justice Alito, joined by
94. Id. at 1192 (majority).
95. Id. at 1225-1226 (Alito, J., dissenting).
96. Id. at 1196 (majority).
97. Wyeth, 129 S. Ct. at 1202-1203.
98. 71 Fed. Reg. 3922, 3935 (Jan. 24, 2006).
99. Id
100. Wyeth, 129 S. Ct. at 1201.
101. In state court, Wyeth had also argued field preemption, but abandoned that claim in the U.S. Supreme
Court. Id. at 1192.
102. Id. at 1193 (quoting Hines, 312 U.S. at 67).
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Chief Justice Roberts and Justice Scalia. We begin with the majority opinion.
After setting forth the facts and regulatory background, Justice Stevens begins his
preemption analysis with what he calls the "two cornerstones of our pre-emption
analysis. First, 'the purpose of Congress is the ultimate touchstone in every pre-emption
case.' ,,103 The second "cornerstone" he cites is the so-called presumption against
preemption, the principle that especially when Congress legislates in a field traditionally
occupied by the States, preemption should be found only if that was "the clear and
manifest purpose of Congress."' 04 This last statement, while seemingly boilerplate,
actually has a great deal of significance because, prior to the Wyeth decision, there was
serious doubt about whether the presumption against preemption applied in cases
involving implied preemption.105 The Wyeth majority, however, unambiguously holds
that the presumption applies to both express and implied preemption, rejecting the
dissent's arguments to the contrary. 106
Turning then to the substantive analysis, the majority begins by quickly rejecting
Wyeth's physical impossibility claim based on its conclusion, noted above, that FDA
regulations permitted Wyeth to supplement its warning label without prior FDA
approval. Given this fact, the majority held, it was not physically impossible for Wyeth
to provide stronger warnings for Phenergan and comply with the FDCA.1 07 Notably,
neither Justice Thomas concurring separatelylo8 nor Justice Alito in dissentl09 appeared
to question the majority's reading of the relevant statute and regulations in this respect
(though as we'll see, Justice Thomas did phrase the conflict analysis a bit differently
from the majority).
Wyeth's purpose/obstacle preemption claim elicited a more lengthy analysis (and
some sharp disagreements among the justices, as we shall see). The majority begins its
discussion by reviewing the history of the FDCA, noting that throughout its 70 year
history Congress had never provided a federal monetary remedy for consumers injured
by unsafe drugs and had never expressly preempted state tort law despite Congress's
awareness of its continuing existence. From this, the Court concluded that Congress did
not view state tort litigation as an obstacle to federal regulation. 110 The majority then
turned its attention to the FDA's 2006 regulatory Preamble endorsing preemption, and
how it should influence the Court's analysis. Justice Stevens begins by noting that the
FDA in this case had not issued a regulation with the force of law which conflicts with
state law (though he notes that even in that situation "the Court has performed its own
conflict determinations" without relying on agency "proclamations of pre-emption"). 11 1
He also notes that Congress has not explicitly authorized the FDA to preempt state law,
103. Wyeth, 129 S. Ct. at 1194 (quoting Lohr, 518 U.S. at 485).
104. Id. at 1194-1195 (quoting Lohr, 518 U.S. at 485).
105. See Young, supra n. 37, at 882-883 (arguing that presumption applies only in express preemption
cases).
106. Wyeth, 129 S. Ct. at 1195 n. 3.
107. Id at 1196-1199.
108. Id. at 1208-1211 (Thomas, J., concurring in the judgment).
109. Id. at 1221 (Roberts, C.J., Alito & Scalia, JJ., dissenting) ("[t]o be sure, federal law does not prohibit
Wyeth from contraindicating 1V push").
I 10. Id. at 1199-1200.
111. Wyeth, 129 S. Ct. at 1200-1201.
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suggesting that this fact has some relevance to the question of judicial deference to the
agency's pronouncements. Next, in a critical passage, the majority concedes that in past
cases the Court has given "some weight" to "an agency's views about the impact of tort
law on federal objectives," but insists that the Court has never "deferred to an agency's
conclusion that state law is pre-empted."11 2 In other words, the Wyeth majority seems to
clearly adopt the distinction (advocated by commentators such as Ernest Young, Nina
Mendelson, and Catherine Sharkey) between deference to agency views regarding the
substantive impact of state law on a federal regulation and deference regarding the
ultimate question of preemption, rejecting any sort of deference on the latter issue (at
least absent an agency regulation with the force of law).
Having accepted this distinction, that then left Justice Stevens with the question of
whether the Court should defer to the view expressed by the FDA that state tort law
interfered with the FDCA's regulatory scheme. Citing United States v. Mead Corp.113
and Skidmore v. Swift & Co.,114 the Court held that the FDA's views would receive
Skidmore deference, meaning that the weight the Court would "accord the agency's
explanation . . . depends on its thoroughness, consistency, and persuasiveness." 11 5
Applying this standard, the Court concluded that absolutely no deference was due to the
FDA's interpretive position. The Court gives many reasons for this lack of deference,
including: (a) that the 2006 Preamble was issued without notice or comment, and so
without input from States or other parties; (b) that the preamble is at odds with
Congress's apparent purpose; and (c) that the Preamble represents a "dramatic change in
position" because for decades prior to 2006 the FDA had indicated that it did not
consider state tort law to interfere with federal regulation, a position which it indeed held
in 2000 when Levine was injured (the Court also cited the FDA's change in position as
the reason it did not defer to the United States' amicus brief urging a finding of
preemption).116 Having concluded that Congress did not intend to preempt state law and
having rejected deference to the agency's arguments to the contrary, the Court of course
rejected Wyeth's purpose/obstacle preemption claim. 117
3. Concurring Opinions
Although he joined the majority opinion in its entirety, Justice Breyer authored a
112. Id. at 1201 (citation omitted) (emphasis in original).
113. 533 U.S. 218, 234-235 (2001).
114. 323 U.S. at 140.
115. Wyeth, 129 S. Ct. at 1201. Under the Court's holding in Mead Corp., Skidmore deference and not
Chevron deference would appear to be appropriate here because the FDA Preamble did not have the force of
law. Mead Corp., 533 U.S. at 226-227. Of course, the Court's later decision in Barnhart v. Walton creates
some serious uncertainties about what exactly the holding of Mead was, but in Wyeth at least, the Court appears
to have adhered to a fairly simple "force of law" interpretation of Mead. See Barnhart v. Walton, 535 U.S. 212
(2002); see generally Cass R. Sunstein, Chevron Step Zero, 92 Va. L. Rev. 187 (2006).
116. Wyeth, 129 S. Ct. at 1201-1202.
117. Id. at 1204. In an intriguing footnote towards the end of its opinion, the majority reiterates that the FDA
had not, during the regulatory proceedings, considered and rejected a stronger warning against IV-push. Id. at
1203 n. 14. This suggests that if the FDA had in fact rejected such a warning, the Court might have found
preemption here-though the majority is admittedly ambiguous on this point. If this is a fair reading of the
majority opinion, it bears noting that Wyeth may be a narrower decision than it first appeared to be because, on
slightly different facts, it might have turned out differently.
214 Vol. 45:197
WYETH V. LEVINE AND AGENCYPREEMPTION
brief concurring opinion as well in which he emphasized that an agency such as the FDA
may well have expertise regarding the extent to which state law interfered with federal
regulation. However, Breyer insisted that if the FDA wished to implement its expert
judgment on such issues, it should do so though "lawful specific regulations,"
presumably with the force of law. 118 Such regulations might well, according to Breyer,
have preemptive effect, but no such regulation existed here.
Justice Thomas wrote a lengthy separate opinion concurring in the judgment only.
The opinion begins with a brief exposition of (and ode to) basic principles of federalism.
The opinion then proceeds to analyze each of Wyeth's conflict preemption claims.
Regarding the impossibility claim, Thomas's analysis largely parallels the majority's,
with one major difference. Drawing on Caleb Nelson's work, Thomas argues that, rather
than focusing on physical impossibility, conflict preemption analysis should ask whether
there is a "direct conflict" between state and federal law. 119 Such a conflict might exist
even if it was physically possible to comply with both laws if, for example, federal law
creates a right (but not a duty) to engage in particular behavior which state law forbids.
On the facts of Wyeth, however, Thomas finds no direct conflict because the FDCA and
FDA regulations do not forbid drug manufacturers from changing their warning labels
without FDA preapproval and they also "do not give drug manufacturers an
unconditional right to market their federally approved drug at all times with the precise
label initially approved by the FDA."l20 His reading of the statute, as noted above,
matches the majority's.
It is on Wyeth's second purpose/conflict preemption claim that Thomas departs
sharply from the majority (and, perforce, the dissent). In short, Thomas states that he has
come to consider the entire category of purpose/obstacle implied conflict preemption to
be illegitimate because it permits courts to find preemption based on broad-based
conclusions about congressional purposes which are not rooted in statutory text.121 The
Supremacy Clause, however, only permits federal law enacted pursuant to Article I, § 7
of the Constitution (as well as federal treaties and the federal Constitution itself) to
preempt state law, a requirement which Thomas argues is not satisfied by nontextual
congressional purposes discovered or constructed by courts. Having stated his basic
conclusion, the bulk of the separate opinion traces the history of the purpose/obstacle
prong of the Court's preemption analysis from the 1941 Hines v. Davidowitz decisionl22
through the 2000 Geier decision.123 The thrust of Thomas's analysis is that
purpose/obstacle preemption is inherently illegitimate because it permits courts to find
preemption even when Congress has not expressly preempted state law and there is no
direct conflict between federal and state law. Indeed, Thomas goes so far as to question
the entire underlying assumption of this form of analysis, which is that statutes have
single, overarching "purposes" which can be frustrated by state law. As Thomas sensibly
118. Id. at 1204 (Breyer, J., concurring).
119. Id. at 2109 (Thomas, J., concurring in the judgment) (citing Nelson, supra n. 4, at 260-261).
120. Wyeth, 129 S. Ct. at 1210.
121. It should be noted that Thomas's rejection of purpose/obstacle preemption mirrors Caleb Nelson's
conclusion on this point, though following a somewhat different line of analysis. See Nelson, supra n. 4, at 265.
122. 312 U.S. at 67.
123. Geier, 529 U.S. 861.
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points out, statutes are often the product of legislative compromises and so often reflect
multiple, even conflicting purposes such as, for example, a desire to create an effective
federal regulatory program and to preserve state tort remedies, even if they somewhat
interfere with that program.124 This stark fact, Thomas argues persuasively, makes much
purpose/obstacle analysis frankly incoherent. Thomas concludes by castigating the
majority for relying on factors such as congressional silence to ferret out a congressional
purpose to retain state tort law, which Thomas doubts exists, and which, in any event, is
not relevant to proper preemption analysis.125
4. Dissenting Opinion
Justice Alito wrote a lengthy and vigorous dissenting opinion which was joined by
Chief Justice Roberts and Justice Scalia. As noted above, the dissent disagrees with the
majority's reading of the facts in a few respects. (Notably, the dissent states its beliefs,
contrary to the majority, that the FDA had given close attention to whether Wyeth's
warnings regarding IV-push administration were adequate and that the Phenergan
warnings in effect in 2000 specifically warned about the risks of IV-push
administration.). 12 6 More importantly, however, the dissent views the case in
fundamentally different terms than the majority. From the dissent's perspective, the issue
raised by the case is "whether a state tort jury can countermand the FDA's considered
judgment that Phenergan's FDA-mandated warning label renders its intravenous (IV) use
'safe.' ,127 Phrased that way, and given its factual assumptions, the dissent thought the
answer obvious: surely a state jury cannot second-guess the FDA's expert judgment in
this matter, and the majority's conclusion to the contrary undermines the FDA's
conclusion that IV-push administration of Phenergan was safe and effective given the
labeling that Wyeth used and the FDA had approved.
Much of the disagreement between the majority and dissent centers around their
different readings of the factual record in this case, particularly the degree to which the
FDA had made a considered judgment to reject stronger warnings for Phenergan
regarding IV-push administration as well as disagreements about whether this case could
be distinguished from the Court's earlier Geier decision. In addition, the dissent was
clearly influenced to some extent by its doubts about the jury's conclusion that
inadequate warning was causally related to Levine's injury,128 doubts which the majority
correctly points out are not truly relevant to the preemption issue.129 These are all
relatively narrow disagreements which are not truly relevant to our topic. There are also,
however, several broader issues regarding agency preemption authority where the dissent
sharply disagrees with the majority. First of all, the dissent rejects the majority's
suggestion that conflict preemption should be limited to situations where an agency
expresses its preemptive intent through notice-and-comment rulemaking. 130 Second, the
124. Wyeth, 129 S. Ct. at 1215 (Thomas, J., concurring in the judgment).
125. Id at 1215-1216.
126. Id. at 1225-1226 (Roberts, C.J., Alito & Scalia, JJ., dissenting).
127. Id. at 1218.
128. Id. at 1217-1218.
129. Wyeth, 129 S. Ct. at 1194 n. 2 (majority).
130. Id. at 1227-1228 (Roberts, C.J., Alito & Scalia, JJ., dissenting).
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dissent argues (quoting previous opinions by Justice Breyer) that the FDA's expert
determination, published in its regulatory preamble, that state duty-to-warn tort liability
would interfere with the FDA's regulatory program, was entitled to judicial deference, as
was the amicus brief filed by the agency to the same end. 13 1 Regarding the majority's
argument that the preamble did not have the "force of law" (a point obviously related to
the lack of notice-and-comment rulemaking), the dissent argues that this is irrelevant
since the FDA's decision to approve Phenergan's label was an adjudicatory decision
which did have the force of law and which preempted Levine's tort claim.132 It might be
noted in passing that this part of the dissent's reasoning seems incorrect; because an
adjudication cannot have future, binding force on non-parties, 133 it is difficult to see how
the FDA's adjudication of Wyeth's new drug application could preempt Levine's later-
arising tort claims. Third, the dissent (as noted earlier) flatly rejects the majority's
conclusion that the "presumption against preemption" should apply in cases involving
conflict preemption. 134 Finally, the dissent objects to the majority's refusal to defer to
the FDA because its current argument in favor of preemption represents a change in the
agency's position, pointing out that in other preemption cases the Court has tended to
defer to an agency's current, not its past, positions. 135
All in all, then, there are obvious and deep differences between the majority and
dissenting opinions regarding the preemptive power of agencies. Where the majority
seemed to insist on fairly formal agency action, ideally notice-and-comment rulemaking,
for an agency to express its preemptive intent, the dissent would impose no such
requirement. Where the majority rejects deference, the dissent strongly favors it. And
where the majority generally expresses hostility towards preemption, but especially
towards preemption by administrative agencies, the dissent expresses no such hostility.
In conclusion, then, the broader theoretical questions raised by agency preemption were
aired more clearly, and more explicitly, in the various opinions in Wyeth v. Levine than
in most recent preemption cases. In the next Part, we will explore the impact of this
decision on the law of agency preemption. Before turning to those questions, however,
we need to explore one more recent development in the area of agency preemption, a
development which occurred not in the courts, but in the executive branch.
E. Enter the President
On May 20, 2009, two months and sixteen days after Wyeth was decided by the
Supreme Court, President Barack Obama issued a "Memorandum for the Heads of
Executive Departments and Agencies" on the subject of preemption. 136 Building on
President Bill Clinton's Executive Order (E.O.) 13132,137 (on which more later), in his
Memorandum President Obama announced his Administration's policy "that preemption
of State law by executive departments and agencies should be undertaken only with full
131. Id. at 1228-1229.
132. Id. at 1228.
133. See generally NLRB v. Wyman-Gordon Co., 394 U.S. 759 (1969); supra n. 70.
134. Wyeth, 129 S. Ct. at 1228-1229, 1229 n. 14 (Roberts, C.J., Alito & Scalia, JJ., dissenting).
135. Id. at 1229.
136. Preemption, supra n. 2.
137. Exec. Or. 13132, 64 Fed. Reg. 43255 (1999).
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consideration of the legitimate prerogatives of the States and with a sufficient legal basis
for preemption." The substantive provisions of the Memorandum read as follows:
To ensure that executive departments and agencies include statements of preemption
in regulations only when such statements have a sufficient legal basis:
1. Heads of departments and agencies should not include in regulatory preambles
statements that the department or agency intends to preempt State law through the
regulation except where preemption provisions are also included in the codified regulation.
2. Heads of departments and agencies should not include preemption provisions in codified
regulations except where such provisions would be justified under legal principles
governing preemption, including the principles outlined in Executive Order 13132.
3. Heads of departments and agencies should review regulations issued within the past 10
years that contain statements in regulatory preambles or codified provisions intended by
the department or agency to preempt State law, in order to decide whether such statements
or provisions are justified under applicable legal principles governing preemption. Where
the head of a department or agency determines that a regulatory statement of preemption or
codified regulatory provision cannot be so justified, the head of that department or agency
should initiate appropriate action, which may include amendment of the relevant
regulation. 138
This Memorandum has some immediate and dramatic implications for agency
preemption. First and foremost, it flatly bans the practice, followed by the FDA in 2006,
of announcing preemptive intent in regulatory preambles, and it orders agency heads to
review any such preambles issued in the past decade (i.e., during the second Bush
Administration). Second, it orders agencies to preempt state law only when justified by
legal principles, including principles outlined in E.O. 13132. To understand the
significance of this requirement (surely requiring agencies to follow "legal principles" is
not controversial?), a closer look at E.O. 13132 is necessary.
President Bill Clinton issued E.O.13132, titled simply Federalism, on August 4,
1999. Most of the Order recites general principles of federalism, orders agencies to
interfere with state discretion to the minimum extent possible, and requires agencies to
consult with state and local officials when their actions have federalism implications
(interestingly, Nina Mendelson provides quite compelling empirical evidence that federal
agencies have largely ignored E.O. 13132 and its predecessor during both the Clinton
and second Bush administrationsl 39). Section Four of the Order deals specifically with
preemption. The most important of its requirements are: (a) that agencies shall construe
statutes to preempt state law "only where the statute contains an express preemption
provision or there is some other clear evidence that the Congress intended preemption of
State law, or where [state law] conflicts with . . . the Federal statute"; and (b) if the
statute does not preempt, "agencies shall construe any authorization [to issue regulations]
as authorizing preemption of State law by rulemaking only when the exercise of State
authority directly conflicts with the exercise of Federal authority ... or there is clear
evidence to conclude that the Congress intended the agency to have the authority to
preempt state law."14 0
138. Preemption, supra n. 2.
139. Mendelson, A Presumption, supra n. 34, at 718-719.
140. Exec. Or. 13132, 64 Fed. Reg. at 43257.
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Between them, the Obama Memorandum and E.O. 13132 (which has never been
revoked, though it was mostly honored in the breach during the second Bush
Administration) appear to resolve many of the specific issues and concerns discussed
above. By requiring codification of preemptive regulations, the Memorandum bans the
sort of preemption-by-stealth attempted by the FDA in 2006. E.O. 13132 appears to go
even further by permitting agencies to interpret statutes to preempt state law only if
"clear evidence" exists of Congress's preemptive intent, and by permitting agencies to
themselves preempt state law only in instances of a "direct conflict" between federal and
state law or where there is "clear evidence" that Congress intended to authorize agency
preemption. If the Obama Administration follows through on the President's expressed
resolve to adhere to E.O. 13132, it would seem that many of the conflicts regarding the
appropriate scope of agency preemptive authority have been resolved. In fact, however,
it is probably too early to declare the battles resolved because the Obama Memorandum
and E.O. 13132 have important limitations. 14 1
The most important limitation of the Obama Memorandum and E.O. 13132 is that
they directly constrain only executive agencies and departments, not independent
agencies. The Obama Memorandum, by its terms, is directed only to executive
departments and agencies, and while E.O. 13132 does state that independent agencies are
"encouraged" to comply with the Order, 142 that is an implicit admission that they have
no obligation to do so. As such, the possibility remains open that independent agencies
will continue to claim expansive preemptive authority during the coming years.
Second, the debate over whether a "clear statement" by Congress should be
required before agencies claim express preemptive authority is not quite resolved by
E.O. 13132 or the Obama Memorandum. E.O. 13132 does require "clear evidence" of
congressional intent to authorize agency preemption, but that is not quite the same as a
clear statement rule, which would require an express and unambiguous authorization of
preemption. "Clear evidence" is a pliable standard, and it is quite easy to envision
agencies finding such evidence in statutory structure, even absent plain language
mentioning preemption. Thus, the question of whether a grant of general rulemaking
power by Congress authorizes agency preemption remains unresolved.
Third, E.O. 13132 continues to permit agencies to construe a statute to preempt
state law in case of a "conflict."1 4 3 The term "conflict" would appear to incorporate not
only physical impossibility, but also purpose/obstacle preemption (which, remember, is a
branch of implied conflict preemption). Thus, an agency remains empowered to interpret
a federal statute to preempt state law if it concludes that state law stands as an obstacle to
Congress's purposes. This, however, is precisely what the FDA did in its 2006
Preamble. 144 Of course, under the Obama Memorandum, the FDA can no longer make
such an argument in a preamble; but it remains able to do so in a codified regulation or,
for that matter, in an amicus brief.
141. For simple political reasons, conflicts over agency preemption are, of course, likely to arise less
frequently during the Obama Administration than during the second Bush Administration.
142. Exec. Or. 13132, 64 F.R. at 43259.
143. Id. at 43257.
144. 71 Fed. Reg. at 3934-3936.
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Fourth, E.O. 13132 permits agencies to preempt state law themselves in case of a
"direct[ ] conflict[ ]" between federal and state law. 14 5 The phrase "direct conflict" might
be read to include only physical impossibility, but that is not an inevitable reading.
Admittedly, equating "direct conflict" with physical impossibility is probably the better
understanding, and in Wyeth, Justice Thomas argues that the Court has generally used the
term "direct conflict" interchangeably with physical impossibility. But then Thomas
himself goes on to suggest that "direct conflict" should be a broader category than
impossibility.146 Moreover, on a few occasions the Court does appear to have used the
phrase "direct conflict" to refer to both impossibility and purpose/obstacle
preemption. 147 Thus there is enough play in the joints of this part of E.O. 13132 that it
may not fully foreclose the possibility that an agency, on its own authority, might
preempt state law on the basis of a conclusion that state law stands as an obstacle to the
purposes of a federal regulatory scheme. Given the capaciousness of purpose/obstacle
preemption, this is a broad power indeed.
Finally, the most obvious limitation of the Obama Memorandum and E.O. 13132 is
that they can always be revoked by a future administration or ignored by agencies.148
Presidential revocation of the Obama Memorandum is certainly a real, albeit not
imminent possibility, and the history of administrative flouting of E.O. 13132 recited by
Nina Mendelson1 49 suggests that ignoring these presidential commands is also quite
plausible. For all of these reasons, the issue of agency preemption has likely not gone
away, though it may enter a period of short-term abeyance. Continued attention to the
these issues is therefore quite justified.
II. AGENCIES AND CONGRESS
As discussed in the previous Part, underlying the debate about agency preemption
are large, institutional questions regarding the relative institutional competencies of
Congress and administrative agencies in determining the ideal division of authority
between the federal and state governments. What insights does the Wyeth decision offer
on these issues? It is to that question that we now turn.
A. The Impact of Wyeth
Let us begin with the relatively narrow question of what doctrinal impact Wyeth v.
Levine is likely to have on the law of agency preemption. It is of course difficult to know
for certain what that impact will be without knowing how future courts will use and cite
the opinion, but some educated guesses are possible. First of all, it does seem relatively
clear that Wyeth has resolved one doctrinal question, holding that the presumption
against preemption applies in implied conflict preemption cases as well as in express
145. Exec. Or. 13132, 64 F.R. at 43257.
146. Wyeth, 129 S. Ct. at 1209 (Thomas, J., concurring in the judgment).
147. See e.g. Boyle v. United Techs. Corp., 487 U.S. 500, 504 (1988); Rose v. Rose, 481 U.S. 619, 632
(1987); Philko Aviation v. Shacket, 462 U.S. 406,410-411 (1983).
148. Since neither the Memorandum nor the E.O. create judicially enforceable rights, an agency's ignoring
of either provision would not assist a litigant challenging agency preemption.
149. Mendelson, A Presumption, supra n. 34, at 718-719.
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preemption cases. The majority explicitly so holds, much to the dissent's chagrin. Of
course, there is some doubt about the significance of this holding-commentators point
out that the Court's invocation and use of the presumption against preemption has been
quite inconsistent.150 Nonetheless, even if at the Supreme Court level this holding may
not have great significance, it is likely to have some impact on decisions in the lower
federal courts and in state courts where, after all, most cases are actually decided.
On more specific issues relating to agency preemptive authority, however, Wyeth
is rather less clear. The first set of such questions tends to revolve around agency
regulations which seek expressly to preempt state law, and in particular about agency
authority to issue such regulations. Wyeth, of course, did not directly address this area
because the FDA had not adopted preemptive regulations (the FDA Preamble was not, to
reiterate, a regulation with the force of law). Nonetheless, the Wyeth majority does
evince a distinct tone towards agency preemption, and that tone is generally hostile. For
example, in deciding what weight to give the FDA's views on preemption, the majority
relies heavily on the fact that "Congress has not authorized the FDA to pre-empt state
law directly," contrasting the FDA's lack of express preemptive authority with other
agencies to whom Congress has expressly delegated preemptive power.151 While not
rising to the level of a holding, this reasoning does suggest that an admittedly bare
majority of the Justices is endorsing the view that agency preemptive authority requires
an express delegation of preemptive power by Congress, not just a general delegation of
rulemaking authority. Again, the jury is still out on this issue, but perhaps the writing is
on the wall (to happily mix a metaphor).
That leaves the question of conflict preemption. Wyeth leaves untouched the basic
proposition that "an agency regulation with the force of law can pre-empt conflicting
state requirements,"l52 a proposition which, as noted above, is not truly controversial.
Importantly, however, Wyeth unambiguously states that when an agency expresses its
views on whether state law conflicts with federal law (presumably either a statute or an
agency regulation), courts do not defer to the "agency's conclusion that state law is pre-
empted."' 5 3 Instead, deference, if any, is given only to the "agency's explanation of how
state law affects the regulatory scheme." 1 54 Again, this is an important clarification of
existing law, adopting, as noted earlier, a dichotomy generally favored by scholars.
The final, probably critical question, is what level of deference is due to the
agency's views regarding the interaction of state and federal law. Here, unfortunately,
the Wyeth decision is less than crystal clear. The Court clearly applies Skidmore rather
than Chevron deference, but that decision may have been driven more by the informal
nature of the FDA Preamble than by the preemption context-i.e., the Court does not
foreclose the possibility that a future, more formal statement of the agency's views on
deference (perhaps as the result of a formal adjudication) might deserve Chevron
150. See Sharkey, supra n. 33, at 458-459, 458 n. 30; see also Cuomo v. Clearing House Assn., L.L.C, 129
S. Ct. 2710, 2720 (2009) (declining to invoke presumption, in a case decided less than four months after
Wyeth).
151. Wyeth, 129 S. Ct. at 1201, 1201 n. 9.
152. Id at 1200.




deference. Moreover, the Court's application of Skidmore deference is also somewhat
perplexing. The majority's bottom line, of course, is clear: "the FDA's 2006 preamble
does not merit deference."155 However, the Court had earlier conceded that agency
views on the impact of state law on federal regulation merited "some weight," especially
in highly technical areas (which FDA regulation of drugs surely is).156 Why, then, the
Court did not give any weight to the FDA's views here is rather unclear. One reason
given by the Court is that the FDA's views are "at odds with what evidence we have of
Congress' purposes"1 57 ; but that is nonsensical since the question of whether state tort
law interferes with federal regulation is surely independent of whether Congress intended
to tolerate such interference. The Court also heavily emphasizes the fact that the FDA
Preamble represents a change in position for the agency.158 Again, however it is not
quite clear why that is significant. In another administrative law case decided just two
months after Wyeth, the Court explicitly held that an agency change of position does not
elicit any special judicial review or suspicion, 15 9 and the FDA's 2006 Preamble provided
a quite thorough explanation of why it considered recent state tort decisions to threaten
the balance drawn by the FDCA.160 Finally, the majority also relies heavily on the fact
that the FDA had not enacted a regulation with the force of law to reject deference and as
the primary means to distinguish the Court's earlier Geier decision.161 Once more,
however, the Court shoots and misses. In Geier, the question had been whether state tort
law interfered with federal policies expressed in an agency regulation with the force of
law. In Wyeth, the question was whether state tort law interfered with federal policies
expressed in the FDCA and in the FDA's decision to approve Wyeth's Phenergan
warning label, an adjudicatory decision with the force of law. But in both cases, the
agency's views regarding whether such interference occurred were not expressed in
regulations, they were expressed less formally, including (as Justice Alito's dissent
points out) in amicus briefs. 162 In short, while the tone of the Wyeth majority towards
deference is an unrelentingly hostile one, Justice Stevens's opinion notably fails to
explain when deference is justified and when it is not.
The Wyeth v. Levine decision thus provides some, but only limited clarity on issues
relating to agency preemption. One way of reading Wyeth, a reading clearly hinted at by
the dissent, is that, in writing this opinion, Justice Stevens was converting into holdings
views about (and hostility to) agency preemption expressed in his earlier dissents in the
Geier and Watters cases. Some support for this position can be found in the fact that the
Geier dissent was joined by Justices Souter, Thomas, and Ginsburg, all of whom also
voted for the result in Wyeth. This view, while somewhat convincing, raises as many
questions as it answers. For one thing, it cannot explain why Justices Kennedy and
Breyer joined Stevens's opinion. More oddly, Stevens's dissent in Watters was joined by
155. Id.
156. Wyeth, 129 S. Ct. at 1201 (quoting Geier, 529 U.S. at 883).
157. Id. at 1201.
158. Id. at 1201-1203.
159. FCC v. Fox TV Stations, Inc., 129 S. Ct. 1800, 1810-1811 (2009).
160. 71 Fed. Reg. at 3934-3936.
161. Wyeth, 129 S. Ct. at 1203.
162. Id. at 1228-1229 (Roberts, C., Alito & Scalia, JJ., dissenting) (citing Geier, 529 U.S. at 881, 883).
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Chief Justice Roberts and Justice Scalia, the same pair that joined Justice Alito's Wyeth
dissent. In short, while Justice Stevens has quite consistently, for the past decade at least,
expressed views hostile to agency preemption, the other justices do not seem to take any
consistent position on this matter, often joining opinions which seem to flatly contradict
each other. Given the uncertainties noted above regarding the precise scope of the
holding in Wyeth, this situation seems to promise more muddle to come.
B. Institutional Competencies and Federalism
Wyeth's contributions to doctrinal transparency in the area of agency preemption,
then, are real, but limited. What of the deeper institutional and constitutional issues
lurking here-does Wyeth provide any clarity? Again, the answers are mixed. As
discussed above, one of the fundamental divisions driving views about agency
preemptive authority revolve around the relative institutional capacities of Congress and
agencies to properly consider the interests of the sovereign states in making preemptive
decisions. Unsurprisingly, the Justices in Wyeth do not directly confront these questions.
There are, however, undoubtedly clear tones expressed in the opinions on this issue
which may be of some relevance in later decisions.163 The five justice majority, lead by
Justice Stevens, clearly has doubts about agency capacity to consider state interests.
Justice Stevens made this point explicitly in his earlier dissent in Geier,164 and his
hostility to the FDA in Wyeth appears to reflect a similar view of agencies. Justice
Thomas avoids the question by rejecting the doctrinal framework on which the FDA's
support of preemption was built, but Justice Alito's opinion clearly endorses the contrary
view that agencies enjoy expertise and so should be deferred to even when the result is
preemption of state law, implicitly assuming that agencies will give adequate
consideration to states' sovereign interests.
Case closed then, three justices in favor of agency expertise, five justices opposed?
Unfortunately, not. For one thing, while Justice Breyer joins Justice Stevens's opinion in
full, he also writes separately to emphasize the FDA's expertise. His opinion suggests
that the reason he is not deferring to the FDA in this case is because the FDA did not
enact specific regulations.165 This explanation is belied (or at least obfuscated) by the
fact that Justice Breyer himself, in an earlier decision involving FDA preemption, wrote a
separate opinion endorsing agency expertise as expressed in regulations and "through
statements in 'regulations, preambles, interpretive statements, and responses to
comments',"166 and even more confusingly, Justice Breyer was the author of the Geier
majority opinion which deferred to some extent to an agency amicus brief. On the flip
side, as noted above, just two years before Wyeth, Chief Justice Roberts and Justice
163. Cf Universal Camera Corp. v. NLRB, 340 U.S. 474, 487 (1951) ("It is fair to say that in all this
Congress expressed a mood.").
164. Geier, 529 U.S. at 908 (Stevens, Souter, Thomas & Ginsburg, JJ., dissenting) ("Unlike Congress,
administrative agencies are clearly not designed to represent the interests of States, yet with relative ease they
can promulgate comprehensive and detailed regulations that have broad pre-emption ramifications for state
law.").
165. Wyeth, 129 S. Ct. at 1204 (Breyer, J., concurring).
166. Lohr, 518 U.S. at 506 (Breyer, J., concurring in part and concurring in the judgment) (quoting
Hillsborough Co. v. Automated Med. Laboratories, Inc., 471 U.S. 707, 721 (1985)).
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Scalia, Justice Alito's fellow dissenters, joined a dissenting opinion by Justice Stevens
which explicitly and powerfully objected to agency preemptive authority because of
agencies' institutional inability to properly value federalism. 167 As with deference, then,
the bottom line would appear to be that, with respect to the justices' views on larger
institutional questions, all is chaos.
Perhaps it is time, then, to step back and consider the bigger picture along with a
dose of realism. The scholarly debate regarding the institutional merits of Congress and
agencies turns, in essence, on the relative values of the political representation of states
within Congress as opposed to the expertise and more open rulemaking procedures of
agencies. The truth is, however, that the relentless expansion of national authority since
the New Deal, across the decades, enacted through statutes and regulations, and
regardless of which political party controls either Congress or the Presidency, leaves one
with grave doubts that any national entity has any serious incentives or desire to protect
state autonomy. As Ernest Young and Stuart Benjamin point out, in practice,
administrative agencies have demonstrated little inclination to preserve state power.168
At the same time, it is hard to argue with a straight face that either Congress or the
President has seriously prioritized the preservation of state authority over any length of
time. To the extent that Congress appears less inclined to preempt state tort law than
agencies or the President (which it does), it is far from clear that this is because Congress
is responding to the interests of the states as opposed to the plaintiffs' bar. In short, the
true answer to the institutional debate may well be that there are no winners here, that no
federal institution can be trusted to protect state interests.
If one accepts this bleak but plausible conclusion, then a difficult question arises.
Historically, state autonomy was protected by limiting the scope of national power.
National power, in turn, was limited through two mechanisms: enforcing limits on the
scope of the national government's enumerated powers, especially the commerce
clause,169 and restricting the power of Congress to delegate its authority to
administrative agencies through the Nondelegation Doctrine, thereby limiting the
effective reach of federal law. 170 Both of those restrictions, however, were essentially
eliminated after 1937 and, other than a brief and inconsequential flirtation with reviving
commerce clause restrictions from 1995 through 2000,171 there are no signs that the
modern Supreme Court has any intention of restoring those limits.172 Finally, at least
since 1984, it has been a fundamental tenet of our system that administrative agencies
acting within their spheres of authority are entitled to substantial deference from
courts. 173 The result is a system of government with essentially unlimited national
authority, almost all of which is wielded by administrative agencies. This govermental
167. Watters, 550 U.S. at 41 (Stevens, J., Roberts, C.J. & Scalia, J., dissenting).
168. Benjamin & Young, supra n. 31, at 2154.
169. See e.g. Hammer v. Dagenhart, 247 U.S. 251 (1918); A.L.A. Schechter Poultry Corp. v. U.S., 295 U.S.
495 (1935).
170. See Panama Refining Corp. v. Ryan, 293 U.S. 388 (1935); Schechter Poultry, 295 U.S. 495.
171. See e.g. US. v. Lopez, 514 U.S. 549 (1995); US. v. Morrison, 529 U.S. 598 (2000).
172. See Gonzales v. Raich, 545 U.S. 1 (2005) (rejecting a commerce clause challenge to a congressional
statute regulating the growing of marijuana at home for medical purposes); Whitman v. Am. Truckers Assn.,
531 U.S. 457 (2001) (largely acknowledging the modem demise of the Nondelegation Doctrine).
173. See Chevron, 467 U.S. 837.
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structure was born of the perceived need, under modem circumstances, for expeditious,
expert, and centralized regulatory authority. The question then arises, if citizens and the
courts have accepted the need for this structure in all other areas, at the expense of
structural federalism, why should there be any special rules regarding preemption?
Nowhere else do courts insist on specific delegations of authority, and nowhere else do
courts deny deference to the expert opinions of agencies, so why in the area of
preemption?
The answer to this question, if one exists, must lie in some vision of why
preemption is special, which, in turn, derives from an understanding of why federalism
matters. Much of the discussion of federalism in our society focuses on the supposed
practical benefits of federalism such as efficiency, maximizing individual choice by
permitting local majorities to decide issues, and permitting experimentation.1 74 In fact,
however, as The Federalist Papers (and, for that matter, the context of the American
Revolution) make quite clear, the original goal of a federal system of dual sovereigns
was neither efficiency nor other perceived utilitarian benefits, it was to restrict the power
of the government, especially the federal government, by creating competing loci of
power within our society. James Madison made this point explicitly in Federalist No.
51175 and in Federalist No. 46, where he set forth in detail the mechanisms by which
state governments could resist national tyranny or usurpations of power.176 And there is,
of course, also the Second Amendment with its vision of state militias resisting national
military authority, which further confirms this understanding. Such resistance, along with
the division of authority between separate sovereigns and the competition for political
favor between different levels of officials, is not particularly likely to yield an efficient
government or optimal public policy outcomes, but it is nonetheless a fundamental
aspect of our structure of government for completely separate, structural reasons.
Consider now administrative agencies. Scholars such as Brian Galle, Mark
Seidenfeld, and Gillian Metzger are drawn to agencies because, in their view (and their
view is quite persuasive in this regard), agencies are best placed to determine the
allocation of authority between national and state governments which is likely to yield
the most efficient and best public policy outcomes. The reason is that agencies are
experts and they are efficient. The problem is, of course, that efficiency is beside the
point. The Constitution preserves state authority even when it is inefficient; indeed, in
some sense it divides authority because it is inefficient and so limits the reach of federal
power. Our system of government is not particularly designed to make the trains run on
time, with all that that implies. Insofar as administrative agencies represent the epitome
of centralized, efficient government, it is precisely this fact which makes them such a
threat to the structural functions of federalism. Of course, since the New Deal we have to
some extent accepted that threat by permitting national, administrative authority to
174. See generally Geoffrey R. Stone, Louis Michael Seidman, Cass R. Sunstein, Mark V. Tushnet &
Pamela S. Karlan, Constitutional Law 169-171 (6' ed., Aspen 2009).
175. James Madison, The Federalist No. 51, in The Federalist Papers 261 (Garry Wills ed., Bantam Books
1982).
176. James Madison, The Federalist No. 46, in The Federalist Papers, supra n. 175, at 237. For a more
detailed examination of these issues, see Ashutosh Bhagwat, Cooper v. Aaron and the Faces of Federalism, 52
St. Louis U. L.J. 1087, 1097-1099 (2008).
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expand enormously. Preemption, however, may be one step too far. The reason is that
preemption poses an especially direct threat to structural federalism. When federal law
preempts state law, it completely eliminates state governments as a source of competing
authority in a way that neither the expansion of federal authority alone nor even
cooperative federalism programs accomplish. Preemption, in other words, completely
eliminates state governments as competing loci of power in particular areas, and as
preemption proceeds apace, it threatens to eliminate state governments as loci of power
altogether. That, of course, is an arrow to the heart of structural federalism.
The threat posed by preemption is well demonstrated by the facts of Wyeth v.
Levine and by the increase in federal preemption of state tort law more generally. 177
Federal regulation of industries such as the pharmaceutical industry typically proceeds
on the presumption that expert administrators can create and enforce sufficiently
effective regulatory rules to protect the public from harm. The focus of such programs is
on technical standards, expertise, and command-and-control measures. It is not on
providing compensation for individuals harmed by industry actions. Compensation,
rather, has traditionally been the function of state tort law. 17 Moreover, federal agencies
are, of course, potentially subject to industry capture, creating a risk that firms in a
particular industry will be subject to no effective oversight, while also, if preemption is
found, being freed from any obligation to compensate victims. State tort juries, for all of
their faults, cannot be captured. All of which is to say that federal regulation and state
tort law act as competing forms of regulation which, when overlapping, provide
alternative models of how particular problems should be addressed by government. Such
competition can sometimes lead to inefficiency, but within limits that is one of the costs
of federalism.
Of course, all of the objections to preemption stated above apply equally to
congressional as to agency preemption. Why then should there be any special rules
limiting agency preemption? Part of the answer must lie in the fact that the text of the
Supremacy Clause expressly states that laws passed by Congress (but not regulations
passed by agencies) will displace state law. Yet another part of the answer must lie in
Congress's greater (albeit still limited) accountability, which restricts the extent to which
it is likely to preempt truly popular state law. Another important, and related, part of the
answer must lie in Congress's greater legitimacy. When Congress acts to preempt state
law, such a decision can meaningfully be described as a choice by the People of the
United States to repose their confidence in federal rather than state officials, a choice that
Madison argues in the Federalist should be available to them (though only within
limits).179 But perhaps most importantly, it may well be that it is the sheer inertia and
inefficiency of Congress, what Ernest Young, citing Bradford Clark, calls the
177. See Catherine M. Sharkey, Preemption by Preamble: Federal Agencies and the Federalization of Tort
Law, 56 De Paul L. Rev. 227 (2007).
178. See Wyeth, 129 S. Ct. at 1202 (noting the "distinct compensatory function" of state tort law). Of course,
compensation is not the only function of tort law. Regulation of primary conduct is also an effect and objective
of a tort system. In the context of Wyeth, such regulatory effects can interfere with federal policy, but they can
also complement it by providing pharmaceutical firms with incentives to strengthen label warnings without
FDA prodding (which will often not be forthcoming, given limited agency resources).
179. Madison, supra n. 175, at 237-238.
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"procedural safeguard" of federalism, 180 that provides the strongest answer for trusting
Congress more. Even if Congress had the will to eliminate large swathes of state
authority, this argument goes, it will be unable to do so because of its difficulty in acting,
especially on controversial topics. All of these arguments have some merit, and provide
some practical basis for preferring Congress to agencies as the source of preemption. It
must be conceded, though, that congressional preemption remains a potent threat to
federalism, and that therefore, absent a revival of substantive limits on national power,
all of this debate over agency preemption may be a minor sideshow, fiddling while Rome
burns.
III. WYETH AND THE COURTS
In the previous Part, we discussed the relative roles of Congress and agencies in
preempting state law, and concluded (rather gloomily) that while neither institution is
likely to be particularly committed to protecting state autonomy, on balance, placing
greater responsibility on Congress is probably the best outcome that we can hope for. We
now consider the role of the third branch of government, the judiciary, in protecting state
interests when making preemption decisions. As we shall see, the Wyeth decision, and
Justice Thomas's separate opinion in particular, provides some interesting insights on the
role of the courts in this area.
Just as the question of whether a clear statement rule should be imposed on
congressional delegations of preemptive authority to agencies can be analyzed based on
the comparative institutional advantages of Congress and agencies, the question of
judicial deference to agency preemptive pronouncements can be considered from the
vantage of the comparative institutional strengths of agencies and courts. The greatest
comparative strength of agencies is, of course, their expertise and their familiarity with
the intricacies of federal regulatory programs. In addition, agencies are probably more
politically accountable than courts because of presidential influence, because of
congressional influence, and because agency heads lack life tenure. As a consequence,
agencies may be somewhat more responsive to state interests. On the other hand, courts
also have some comparative strengths. For one, their lack of accountability makes them
less prone to capture by industry and the consequent devaluing of state interests. In
addition, agencies often have incentives to expand their own sphere of authority by
supplanting state law, incentives which are much less relevant to the work of courts.
Finally, and most significantly, judges, unlike agency administrators, are trained to, and
are relatively well placed to, give attention to fundamental constitutional concerns such
as the importance of retaining a strong system of structural federalism.
Arguably, these comparative strengths and weaknesses played out well in the
Wyeth decision. For example, the majority's holding that agencies should be granted
some deference on technical questions regarding the interaction between federal and
state law, while not receiving any deference on ultimate conclusions regarding deference,
nicely balances agencies' expertise with their tendency to undervalue structural
federalism. In addition, the Wyeth majority's ultimate decision not to defer to the FDA's
180. Young, supra n. 37, at 876, 876 n. 44 (citing Clark, supra n. 21).
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2006 Preamble also probably reflects institutional factors, in particular a perception on
the part of the majority that the FDA's decision to support preemption was driven not by
its expert judgment, but rather by politics and perhaps capture. Such a reading certainly
explains the majority's emphasis of the fact that the FDA's 2006 Preamble represented
an unexplained change of position for the agency. Indeed, the Court's special concerns
about agency flip-flops here, which are not necessarily followed in other administrative
contexts even when those flip-flops appear to have been influenced by politics,181 may
well be a product of special judicial sensitivity to underlying federalism values.
All of this, however, may be a bit too sanguine. As Justice Thomas's separate
opinion in Wyeth argues, there is a strong argument to be made that, in recent years,
courts in fact have not been sufficiently sensitive to state interests and have been far too
willing to find preemption without clear authorization from Congress. Thomas traces the
problem to the development and expansion of the purpose/obstacle prong of preemption
analysis, and he makes a compelling case. As Thomas points out, criticism of this
doctrine goes back to its very roots in the 1941 Hines v. Davidowitz decision.182 More
recently, Justice Kennedy sharply criticized the doctrine in his separate opinion in Gade
v. National Solid Waste Management Association, describing the doctrine as creating the
danger of a "judicial inquiry into whether a state statute is in tension with federal
objectives."183 Thomas adds to this by pointing out that the Court's application of the
purpose/obstacle doctrine in the 2000 Geier case permitted the Court to find preemption
even in the face of an express statutory savings clause addressed to state tort law. 184
Indeed, the Court's decision in Geier has obvious and troubling similarities to the FDA's
actions in Wyeth, preempting (or, in the FDA's case, seeking to preempt) state law
without any direct conflict between federal and state law or any indication that Congress
so intended.
If purpose/obstacle preemption is understood as preemption by the courts, then the
problems with it become obvious. Justice Thomas criticizes the purpose/obstacle
doctrine on the grounds that it permits a finding of preemption completely untethered to
any statutory text enacted by Congress, a result which he says violates the Supremacy
Clause's limitation that only laws made pursuant to the Constitution can preempt state
law. Whether or not this textual argument is convincing, there are serious institutional
reasons to be concerned about purely judicial preemption. Judges, like agencies, are not
constituted to represent state interests, and while judges are perhaps more sensitive to
constitutional principles than agencies, that does not ensure that in individual cases they
will place value in retaining particular state laws to which they might otherwise be
ideologically hostile. Moreover, the complete lack of political accountability of judges
means that the States, and citizens, have no practical way (beyond amicus briefs) to exert
influence on courts to preserve state autonomy. Finally, judges, while perhaps not as
efficient as agencies, are far more efficient than Congress. It is true that they play a
181. See e.g Fox TV, 129 S. Ct. at 1810-1811; Chevron, 467 U.S. at 863-864.
182. Wyeth, 129 S. Ct. at 1212-1213 (Thomas, J., concurring in thejudgment) (citing Hines, 312 U.S. at 75-
79 (Stone, J., dissenting)).
183. 505 U.S. 88, 111 (1992) (Kennedy, J., concurring in part and concurring in the judgment).
184. Wyeth, 129 S. Ct. at 1213-1215 (Thomas, J., concurring in thejudgment).
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relatively passive role, since they can only act when litigation is initiated; but in our
complex, litigious society, that is not a particularly high barrier, especially in areas like
preemption where the financial stakes are often extremely high. And once a case is
initiated, it is essentially trivial for a judge to find state law preempted.
In short, there seems a strong argument that Justice Thomas was right on the mark
in Wyeth in suggesting that the real culprit in the preemption area is not the
administrative state, but rather the doctrine of purpose/obstacle preemption itself It is
this doctrine which empowers courts and agencies to seek to preempt state law relatively
easily without any evidence of congressional intent-thereby turning the political and
procedural safeguards of federalism on their head-and without any evidence of a direct
conflict (or as Caleb Nelson puts it, "logical contradiction" 18 5) between state and federal
law. Nelson, indeed, makes quite a compelling argument that the purpose/obstacle prong
of preemption analysis has no textual or historical support, 186 and Nina Mendelson
argues convincingly that purpose/obstacle preemption presents by far the most serious
problems of overbroad agency preemption.' 87 Finally, the abandonment of this prong of
preemption doctrine need not impose a serious burden on the ability of the federal
government to achieve its goals. Express preemption by Congress, and when done
pursuant to a congressional delegation by agencies, remains available. In addition, both
Nelson and Justice Thomas propose a loosening of the impossibility prong of conflict
preemption analysis to capture those situations where state and federal law are truly in
opposition, and so preemption is justified even without an expressly stated congressional
desire to do so.188 Justice Thomas has pointed the way; perhaps it is time for the other
justices to at least explore whether that road might lead to a safer haven for federalism.
IV. CONCLUSION
The law of agency preemption is a muddle. Basic questions, such as the clarity
with which Congress must delegate preemptive power to administrative agencies and the
level of deference courts should provide to agency statements regarding the preemptive
effect of federal law remain unresolved by the Supreme Court. The Court's recent Wyeth
v. Levine decision provides a bit of clarity on some specific matters, such as the level and
nature of judicial deference, and provides some hints of the Court's future direction, but,
in truth, muddle still dominates over clarity. Ultimately, however, this article argues that
much of the debate over agency preemption may be beside the point. While there may be
reasons to somewhat prefer Congress to agencies, or to the courts, as the institution with
the authority to preempt state law, the truth is that no institution of the federal
government appears to have either the incentives, or the will, to truly preserve state law
and state autonomy in a way consistent with maintaining structural federalism.
Nonetheless, if we are to maintain fidelity to our constitutional structure, some
commitment must be retained to preserving states as autonomous and competing sources
of power to the federal government. One promising step in this direction is pointed to by
185. Nelson, supra n. 4, at 260.
186. Id at 265.
187. Mendelson, A Presumption, supra n. 34, at 699-701.
188. Nelson, supra n. 4, at 260; Wyeth, 129 S. Ct. at 1209.
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Justice Thomas's concurring opinion in Wyeth. Thomas argues that the Court should
abandon one of the prongs of the Supreme Court's preemption doctrine, what I call the
purpose/obstacle prong, which preempts state law that "stands as an obstacle to the
accomplishment and execution of the full purposes and objectives of Congress."1 89
Justice Thomas, building on the work of Professor Caleb Nelson, makes a convincing
argument that this prong is dangerous and illegitimate, a conclusion which is bolstered
by a consideration of institutional factors. Here, at least, the Court, if it is so inclined, has
the ability to take some concrete measures to preserve and restore the balance of
federalism.
What is most frustrating about the debate over preemption generally, and agency
preemption in particular, is that so few actors in the area, either agencies, commentators,
or even Justices of the Supreme Court, appear to take seriously the structural significance
of federalism in the preemption context. The underlying concerns raised by federal
preemption of state law are not the efficiency of government or the advancement of
public policy, it is the need to retain states as independent loci of authority within our
system. The threat of preemption is the threat of leaving states as withered hulks, perhaps
cooperating in the implementation of federal programs, but lacking the power and the
means to meet their citizens' needs autonomously. Such a path undermines the very
existence of states as a counterbalance to the national government. States can play this
role only insofar as citizens look to, and participate in, state government, a process which
will inevitably weaken as state authority shrinks. The truth is that despite the New Deal,
until recently state governments have retained their broad authority and historical
dominance in areas of criminal and private law, including consumer protection and tort
law. The recent federal preemptive onslaught threatens these last bastions of state power,
leaving what remains of "Our Federalism" at great risk.
189. English, 496 U.S. at 79 (quoting Hines, 312 U.S. at 67).
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